In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Scott Stuart and Dr. Selwyn Vickers stand side by side smiling.
A Message From the Chairman and President

Learn from the MSK President/CEO and Chair of the Board of Trustees about some of the most important advances in cancer care and science at MSK in 2024.
An illustration of lung develop alongside tumor evolution
In the Lab
Shape-Shifting Stem Cells Are Key to Cancer Metastasis and Immune Evasion

By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.
Cody holds his graduation cap
Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer 

Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.
Does Exercise Improve Survival After a Cancer Diagnosis? An Encouraging New Study

Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study from MSK's Exercise-Oncology Service.
Lymphoma patient Symantha Wilson
Making Immunotherapy Work for More People

Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.
scale
Q&A
Why Are More Young Adults Getting Cancer? Obesity May Be to Blame

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
Illustration of a magnifying glass and DNA sequences
Finding
Machine Learning May Help Classify Cancers of Unknown Primary

MSK investigators report a new tool that may help them determine the origin of some metastatic tumors, potentially leading to better targeted treatments.
Physician standing in front of a whiteboard
Finding
Novel Drug Advancing to Phase II Basket Trial of Solid Tumors

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.
PhD candidate Laura Menocal wearing a mask in the lab
The Path Ahead: How MSK Responded to COVID-19

Learn how Memorial Sloan Kettering Cancer Center kept caring for patients during the response to COVID-19, and how lessons learned during the pandemic are helping cancer care.
A Hodgkin lymphoma survivor who received nivolumab as part of a clinical trial.
In the Clinic
Immunotherapy Drug Approved for Treatment of Hodgkin Lymphoma

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.